MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 2 January 2026, approved zapomeran (Kostaive) mRNA COVID-19 vaccine, for the immunisation of individuals aged 18 years of age and older. 

Zapomeran is given as a…

Continue Reading